REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five ratings firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokers […]
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $16.93 and last traded at $17.32, with a volume of 37946 shares changing hands. The stock had previously closed at $17.23. Wall Street Analysts Forecast Growth RGNX has been […]